Target intelligence / Profile preview

RYR3 divergent transcript (RYR3-DT)

Target: RYR3-DT
Molecular classification: Long non-coding RNA (lncRNA)

Overview

The RYR3 divergent transcript (RYR3-DT, TCONS_l2_00009005) is a long non-coding RNA located near the RYR3 gene, which encodes the ryanodine receptor 3, a calcium release channel involved in muscle and neuronal function[5]. RYR3-DT does not code for a protein and is not known to act as a receptor, enzyme, or other therapeutic protein target. Currently, its specific functions, disease associations, and drug interactions remain unknown, and its naming may cause confusion with the canonical ryanodine receptor 3 protein[5][4].

Other names: TCONS_l2_00009005RYR3-DTRYR3 divergent transcript

Biological functions

Unknown

Disease associations

Unknown

Beyond the preview

Go deeper on RYR3 divergent transcript (RYR3-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RYR3 divergent transcript (RYR3-DT).

Explore the full profile